2 - TI Pharma
2 - TI Pharma 2 - TI Pharma
Diabetogenic Effects of Glucocorticoid Drugs: The Knowns and The Unknowns The studies described in this thesis were performed within the framework of the Dutch Top Institute Pharma, project T1-106. ISBN: 978-94-6191-423-1 Author: Daniël Henri van Raalte Cover Design: Lotje van Lieshout Lay-out: Cyriel van Oorschot, Ipskamp drukkers BV Printed by: Ipskamp Drukkers BV © D.H. van Raalte, Amsterdam, The Netherlands, 2012. No part of this thesis may be reproduced, stored or transmitted in any form or by any means, without prior permission of the author. Financial support by the Dutch Diabetes Research Foundation and the Dutch Arthritis Foundation for the publication of this thesis is gratefully acknowledged. The printing of this thesis was additionally supported by: Boehringer Ingelheim B.V., Eli Lilly Nederland B.V., GlaxoSmithKline B.V., Novartis Pharma B.V., Posthumus Meyjes fonds, Sanofi –Aventis B.V., Servier Nederland B.V., Vrije Universiteit.
- Page 2: Diabetogenic Effects of Glucocortic
- Page 8: Promotor: prof.dr. M. Diamant
- Page 12: CoNTENT Part I Introduction Chapter
- Page 18: PART Introduction I
- Page 24: Chapter 1 General Introduction The
- Page 28: Chapter 1 General Introduction and
- Page 32: Chapter 1 General Introduction The
- Page 36: Chapter 1 General Introduction REFE
- Page 40: Chapter 1 General Introduction 32.
- Page 48: Chapter 2 Glucocorticoids: metaboli
- Page 52: Chapter 2 Glucocorticoids: metaboli
Diabetogenic Effects of Glucocorticoid Drugs:<br />
The Knowns and The Unknowns<br />
The studies described in this thesis were performed within the framework of the Dutch Top<br />
Institute <strong>Pharma</strong>, project T1-106.<br />
ISBN: 978-94-6191-423-1<br />
Author: Daniël Henri van Raalte<br />
Cover Design: Lotje van Lieshout<br />
Lay-out: Cyriel van Oorschot, Ipskamp drukkers BV<br />
Printed by: Ipskamp Drukkers BV<br />
© D.H. van Raalte, Amsterdam, The Netherlands, 2012.<br />
No part of this thesis may be reproduced, stored or transmitted in any form or by any means,<br />
without prior permission of the author.<br />
Financial support by the Dutch Diabetes Research Foundation and the Dutch Arthritis Foundation<br />
for the publication of this thesis is gratefully acknowledged.<br />
The printing of this thesis was additionally supported by: Boehringer Ingelheim B.V., Eli Lilly<br />
Nederland B.V., GlaxoSmithKline B.V., Novartis <strong>Pharma</strong> B.V., Posthumus Meyjes fonds, Sanofi<br />
–Aventis B.V., Servier Nederland B.V., Vrije Universiteit.
Change language